Store-operated Ca2+ entry as a key oncogenic Ca2+ signaling driving tumor invasion-metastasis cascade and its translational potential
Autor: | Jinyan Zhang, Yayan Deng, Qian He, Yue Luo, Rong Liang, Yan Lin, Yongqiang Li, Jiazhang Wei, Fei Liu, Shenhong Qu, Min Li, Jianrong Yang, Jiaxiang Ye, Jingjin Weng |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Cancer Research Stromal Interaction Molecules business.industry Angiogenesis Invasion metastasis medicine.disease Metastasis 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Oncology 030220 oncology & carcinogenesis Cancer research Tumor Cell Migration Medicine Epithelial–mesenchymal transition business Ca2 entry Ca2 signaling |
Zdroj: | Cancer Letters. 516:64-72 |
ISSN: | 0304-3835 |
DOI: | 10.1016/j.canlet.2021.05.036 |
Popis: | Tumor metastasis is the primary cause of treatment failure and cancer-related deaths. Store-operated Ca2+ entry (SOCE), which is mediated by stromal interaction molecules (STIM) and ORAI proteins, has been implicated in the tumor invasion-metastasis cascade. Epithelial-mesenchymal transition (EMT) is a cellular program that enables tumor cells to acquire the capacities needed for migration and invasion and the formation of distal metastases. Tumor-associated angiogenesis contributes to metastasis because aberrantly developed vessels offer a path for tumor cell dissemination as well as supply sufficient nutrients for the metastatic colony to develop into metastasis. Recently, increasing evidence has indicated that SOCE alterations actively participate in the multi-step process of tumor metastasis. In addition, the dysregulated expression of STIM/ORAI has been reported to be a predictor of poor prognosis. Herein, we review the latest advances about the critical role of SOCE in the tumor metastasis cascade and the underlying regulatory mechanisms. We emphasize the contributions of SOCE to the EMT program, tumor cell migration and invasion, and angiogenesis. We further discuss the possibility of modulating SOCE or intervening in the downstream signaling pathways as a feasible targeting therapy for cancer treatment. |
Databáze: | OpenAIRE |
Externí odkaz: |